[go: up one dir, main page]

HUP9701561A2 - N-acilezett-piperidin-származékok, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények - Google Patents

N-acilezett-piperidin-származékok, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények

Info

Publication number
HUP9701561A2
HUP9701561A2 HU9701561A HUP9701561A HUP9701561A2 HU P9701561 A2 HUP9701561 A2 HU P9701561A2 HU 9701561 A HU9701561 A HU 9701561A HU P9701561 A HUP9701561 A HU P9701561A HU P9701561 A2 HUP9701561 A2 HU P9701561A2
Authority
HU
Hungary
Prior art keywords
atom
substituted
saturated
unsaturated
substituents
Prior art date
Application number
HU9701561A
Other languages
English (en)
Inventor
Emmanuel Canet
Alain Dhainaut
Michel Lonchampt
André Tizot
Original Assignee
Adir Et Compagnie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir Et Compagnie filed Critical Adir Et Compagnie
Publication of HU9701561D0 publication Critical patent/HU9701561D0/hu
Publication of HUP9701561A2 publication Critical patent/HUP9701561A2/hu
Publication of HUP9701561A3 publication Critical patent/HUP9701561A3/hu
Publication of HU221811B1 publication Critical patent/HU221811B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány az (I) általánős képletű, új N-szűbsztitűált ciklűsősaminőkra - a képletbenX jelentése -CH=, -CH2- vagy őxigénatőm;R1 jelentése adőtt esetben egy vagy több halőgénatőmmal szűbsztitűáltegyenes vagy elágazó szénláncú, 1-6 szénatőmős alkilcsőpőrt;R2 jelentése a) adőtt esetben egy vagy több halőgénatőmmal és/vagyhidrőxilcsőpőrttal szűbsztitűált telített vagy telítetlen 3-6szénatőmős mőnőciklűsős szénhidrőgéncsőpőrt; b) adőtt esetben egy vagytöbb halőgénatőmmal és/vagy hidrőxil-csőpőrttal szűbsztitűált telítettvagy telítetlen 7-10 szénatőmős pőliciklűsős szénhidrőgéncsőpőrt; c)adőtt esetben egy vagy több halőgénatőmmal és/vagy hdirőxilcsőpőrttalszűbsztitűált telített vagy telítetlen, egyenes vagy elágazó szénláncú1-13 szénatőmős szénhidrőgéncsőpőrt, amely tővábbi szűbsztitűenseketis tartalmazhat;R jelentésefenilcsőpőrt, bifenililcsőpőrt vagy naftilcsőpőrt;5-tagú arőmás gyűrűs csőpőrt, amely 1-4 azőnős vagy eltérőheterőatőmőt tartalmaz;6-tagú arőmás gyűrűs csőpőrt, amely 1-3 nitrőgénatőmőt tartalmaz;telített vagy telítetlen, biciklűsős 9- vagy 10-tagú arőmás csőpőrt,amely 1-4 azőnős vagy eltérő heterőatőmőt tartalmaz;részlegesen telített biciklűsős fent definiált arőmás csőpőrt, amelyegy vagy több karbőnil fűnkciós csőpőrtőt tartalmaz, ésaz R jelentésére fent definiált csőpőrtők bármelyike 1-3szűbsztitűenssel lehet szűbsztitűálva -,valamint őptikai és geőmetriai izőmerjeikre és fiziőlógiásanelfőgadható sóikra vőnatkőzik.A találmány szerinti vegyületek PDE4 inhibítőrők, fenti tűlajdőnságaikkövetkeztében gyógyászati készítények hatóanyagaként alkalmazhatók.(I)ŕ
HU9701561A 1996-09-20 1997-09-19 N-acilezett-piperidin-származékok, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények HU221811B1 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611501A FR2753706B1 (fr) 1996-09-20 1996-09-20 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (4)

Publication Number Publication Date
HU9701561D0 HU9701561D0 (en) 1997-11-28
HUP9701561A2 true HUP9701561A2 (hu) 1998-05-28
HUP9701561A3 HUP9701561A3 (en) 1998-07-28
HU221811B1 HU221811B1 (hu) 2003-01-28

Family

ID=9495928

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701561A HU221811B1 (hu) 1996-09-20 1997-09-19 N-acilezett-piperidin-származékok, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények

Country Status (18)

Country Link
US (1) US5919801A (hu)
EP (1) EP0831090B1 (hu)
JP (1) JPH10101645A (hu)
AT (1) ATE191717T1 (hu)
AU (1) AU718489B2 (hu)
BR (1) BR9704757A (hu)
CA (1) CA2216664C (hu)
DE (1) DE69701662T2 (hu)
DK (1) DK0831090T3 (hu)
ES (1) ES2147427T3 (hu)
FR (1) FR2753706B1 (hu)
GR (1) GR3033509T3 (hu)
HU (1) HU221811B1 (hu)
NO (1) NO313997B1 (hu)
NZ (1) NZ328789A (hu)
PL (1) PL322192A1 (hu)
PT (1) PT831090E (hu)
ZA (1) ZA978462B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769465B2 (en) * 1998-05-22 2004-01-29 Scios Inc. Heterocyclic compounds and methods to treat cardiac failure and other disorders
US6448257B1 (en) 1998-05-22 2002-09-10 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6340685B1 (en) 1998-05-22 2002-01-22 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6589954B1 (en) 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
US6130235A (en) * 1998-05-22 2000-10-10 Scios Inc. Compounds and methods to treat cardiac failure and other disorders
US6867209B1 (en) 1998-05-22 2005-03-15 Scios, Inc. Indole-type derivatives as inhibitors of p38 kinase
IL141335A0 (en) 1998-08-26 2002-03-10 Smithkline Beecham Corp Therapies for treating pulmonary diseases
IL146309A (en) 1999-05-21 2008-03-20 Scios Inc Derivatives of the indole type and pharmaceutical preparations containing them as inhibitors of kinase p38
KR100515905B1 (ko) * 2000-01-31 2005-09-21 주식회사 엘지생명과학 피롤아미드의 새로운 제조방법
US20030207845A1 (en) * 2001-02-08 2003-11-06 Keating Elizabeth T. Method and compositions for treating an inflammatory disease
HUP0300689A3 (en) * 2000-02-08 2003-09-29 Smithkline Beecham Corp Method and compositions for treating an inflammatory disease
DE10035928A1 (de) 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10035927A1 (de) 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
WO2002014280A1 (fr) * 2000-08-11 2002-02-21 Ono Pharmaceutical Co., Ltd. Dérivés de pipéridine et médicaments à base de tels principes actifs
US20040219552A1 (en) * 2001-08-14 2004-11-04 Ali Ait Ikhlef Novel molecular target for neurotoxicity
FR2856595B1 (fr) * 2003-06-27 2008-05-30 Exonhit Therapeutics Sa Methodes et compositions pour le traitement de deficits cognitifs.
CN102026970B (zh) * 2007-11-21 2013-07-31 解码遗传Ehf公司 用于治疗肺部和心血管病症的联芳基pde4抑制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6850M (hu) * 1967-12-05 1969-04-08
US5459151A (en) * 1993-04-30 1995-10-17 American Home Products Corporation N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
US5530012A (en) * 1994-12-22 1996-06-25 Bristol-Myers Squibb Co. 3-alkoxybenzylpiperidine derivatives as melatonergic agents
US5703239A (en) * 1995-06-02 1997-12-30 Bristol-Myers Squibb Company Indanylpiperidines as melatonergic agents

Also Published As

Publication number Publication date
DE69701662D1 (de) 2000-05-18
CA2216664A1 (fr) 1998-03-20
EP0831090A1 (fr) 1998-03-25
JPH10101645A (ja) 1998-04-21
ES2147427T3 (es) 2000-09-01
EP0831090B1 (fr) 2000-04-12
HU9701561D0 (en) 1997-11-28
DK0831090T3 (da) 2000-09-11
FR2753706A1 (fr) 1998-03-27
FR2753706B1 (fr) 1998-10-30
PT831090E (pt) 2000-07-31
NO974253D0 (no) 1997-09-15
GR3033509T3 (en) 2000-09-29
AU3836297A (en) 1998-03-26
PL322192A1 (en) 1998-03-30
ATE191717T1 (de) 2000-04-15
AU718489B2 (en) 2000-04-13
NZ328789A (en) 1998-02-26
NO974253L (no) 1998-03-23
BR9704757A (pt) 1998-09-01
HU221811B1 (hu) 2003-01-28
NO313997B1 (no) 2003-01-13
HUP9701561A3 (en) 1998-07-28
US5919801A (en) 1999-07-06
DE69701662T2 (de) 2000-11-23
CA2216664C (fr) 2002-05-21
ZA978462B (en) 1998-03-24

Similar Documents

Publication Publication Date Title
HUP9701561A2 (hu) N-acilezett-piperidin-származékok, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
HUP9800295A2 (hu) Szubsztituált heterociklusos vegyületek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények, intermedierjeik
HUP9902471A2 (hu) Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
ATE213498T1 (de) Xanthinderivate, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
HUP9802300A2 (hu) N-heteroaril-piridin-szulfonamid származékok, ezeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
HUP9900006A2 (hu) Ciklikus GMP-specifikus foszfo-diészteráz inhibitor vegyületek, előállításuk és ezeket tartalmazó gyógyszerkészítmények
EP0348341A3 (de) Aminoalkylindole, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
ES2055056T3 (es) Derivados de pirimidopirimidina.
HU906402D0 (en) Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance
HUP0102466A2 (hu) Antiösztrogén hatású új benzo-pirán vagy tiobenzo-pirán származékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények
HUP9801838A2 (hu) Specifikus ingerlő aminosav antagonista indolszármazékok
SE7501365L (hu)
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
ATE204278T1 (de) Serotoninergische ergolin derivate
SE9003973L (sv) Glycerol, ett framstaellningsfoerfarande foer desamma samt terapeutiska kompositioner innehaallande dem
HUP9904056A2 (hu) Farnezil-protein-transzferáz inhibitor hatású szubsztituált benzo-ciklohepta-piridin-származékok és alkalmazásuk
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
SE8804688L (sv) Substituerade styrenderivat
ATE112562T1 (de) Acylbenzoxazolinone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.
ATE78254T1 (de) Indol-derivate.
HUP9904040A2 (hu) Piridostigmin és rokon vegyületek többértékű sói
HUP9903424A1 (hu) Új eritromicinszármazékok,eljárás előállításukra és gyógyszerként való alkalmazásuk
AU4583489A (en) New indole derivatives, process for preparing them and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20021205

HMM4 Cancellation of final prot. due to non-payment of fee